NCT01785082

Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test

Prospective, Randomized, Controlled, Multi-centric, Phase III Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 149 (actual)
• Sponsor: Humedics GmbH · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate safety and efficacy of intravenously injected 0.4% 13-C-Methacetin solution for the determination of liver function with the LiMAx-test on patients with partial liver resection. The LiMAx-test is compared with an untreated control group and post-surgical management of both groups is investigated.

Conditions

• Liver Failure

Interventions

Type	Name	Description
DRUG	13-C-Methacetin	intravenous injection of 0.4% 13-C-Methacetin solution, once before partial liver resection, once after partial liver resection

Timeline

• Start date: 2013-01-01
• Primary completion: 2015-09-01
• Completion: 2015-09-01
• First posted: 2013-02-07
• Last updated: 2018-10-25

Locations

4 sites across 1 country: Germany